OnCore Login

Return to Trial Database

HCRN-GI14-198

Phase II Randomized, Double-Blind Study of mFOLFIRINOX Plus Ramucirumab versus mFOLFIRINOX plus placebo in Advanced Pancreatic Cancer Patients

Status

Study Completed

Cancer Type(s)

Pancreatic

Study Contact

Publications

Phase II randomized, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients
  • WL Shaib, M Rupji, TA Khair, EL Robin, BF El-Rayes, TK Huyck, Y Liu, MB Sonbol, TS Bekaii-Saab
Phase II randomized, double-blind, study of mfolfirinox plus ramucirumab versus mfolfirinox plus placebo in advanced pancreatic cancer patients
  • WL Shaib, B O'Neil, BF El-Rayes, SJ Cohen, TA Khair, EL Robin, TK Huyck, RA Redman, AR Sama, M Kassar, TS Bekaii-Saab
Phase II randomized, double-blind, study of mfolfirinox plus ramucirumab versus mfolfirinox plus placebo in advanced pancreatic cancer patients
  • Walid L. Shaib, Rupji Manali, Yuan Liu, Bassel El-Rayes, Patrick Loehrer, Bert O’Neil, Steven Cohen, Tina Khair, Erwin Robin, Timothy Huyck, Tanios Bekaii-Saab

Trial Locations

All sites in which the trial HCRN-GI14-198 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278